MARKET

BIIB

BIIB

Biogen Inc
NASDAQ
117.21
+0.39
+0.33%
Pre Market: 116.45 -0.76 -0.65% 08:58 05/08 EDT
OPEN
117.73
PREV CLOSE
116.82
HIGH
118.00
LOW
116.22
VOLUME
1.27K
TURNOVER
176.53M
52 WEEK HIGH
238.00
52 WEEK LOW
110.04
MARKET CAP
17.17B
P/E (TTM)
11.57
1D
5D
1M
3M
1Y
5Y
1D
Biogen (NasdaqGS:BIIB) Selects Multiple Co-Lead Underwriters for US$1 Billion Fixed-Income Offering
Simply Wall St · 19h ago
Denali Q1 Loss Wider Than Expected, Hunter Syndrome Drug in Focus
NASDAQ · 19h ago
Biogen Price Target Cut to $169.00/Share From $207.00 by Mizuho
Dow Jones · 23h ago
Biogen Is Maintained at Outperform by Mizuho
Dow Jones · 23h ago
Mizuho Maintains Outperform on Biogen, Lowers Price Target to $169
Benzinga · 23h ago
Biogen price target lowered to $169 from $207 at Mizuho
TipRanks · 1d ago
BIOGEN <BIIB.O>: MIZUHO CUTS TARGET PRICE TO $169 FROM $207
Reuters · 1d ago
Stocks Retreat on Concerns About Economic Damage from Tariffs
NASDAQ · 1d ago
More
About BIIB
More
Biogen Inc. is a global biopharmaceutical company. The Company is focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It operates a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS, and FUMADERM for the treatment of severe plaque psoriasis. It also collaborations with Eisai on the commercialization of LEQEMBI for the treatment of Alzheimer's disease and Sage on the commercialization of ZURZUVAE for the treatment of Postpartum Depression (PPD).
Recently
Symbol
Price
%Change

Webull offers Biogen Inc stock information, including NASDAQ: BIIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIIB stock methods without spending real money on the virtual paper trading platform.